相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。MHC Class II Presentation in Autoimmunity
Irina A. Ishina et al.
CELLS (2023)
Recent Advances in PROTAC-Based Antiviral Strategies
Haleema Ahmad et al.
VACCINES (2023)
Harnessing sortase A transpeptidation for advanced targeted therapeutics and vaccine engineering
Eugene M. Obeng et al.
BIOTECHNOLOGY ADVANCES (2023)
Safety and immunogenicity of a skin- and neuro-attenuated live vaccine for varicella: a randomized, double-blind, controlled, dose-escalation and age de-escalation phase 1 clinical trial
Zhao-Jun Mo et al.
LANCET REGIONAL HEALTH-WESTERN PACIFIC (2023)
PROTAC targeted protein degraders: the past is prologue
Miklos Bekes et al.
NATURE REVIEWS DRUG DISCOVERY (2022)
Infectious disease in an era of global change
Rachel E. Baker et al.
NATURE REVIEWS MICROBIOLOGY (2022)
Efficacy and Safety of NVX-CoV2373 in Adults in the United States and Mexico
Lisa M. Dunkle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
Development of a skin- and neuro-attenuated live vaccine for varicella
Wei Wang et al.
NATURE COMMUNICATIONS (2022)
Design of protein-binding proteins from the target structure alone
Longxing Cao et al.
NATURE (2022)
Generation of Premature Termination Codon (PTC)-Harboring Pseudorabies Virus (PRV) via Genetic Code Expansion Technology
Tong-Yun Wang et al.
VIRUSES-BASEL (2022)
A live attenuated virus-based intranasal COVID-19 vaccine provides rapid, prolonged, and broad protection against SARS-CoV-2
Junyu Chen et al.
SCIENCE BULLETIN (2022)
Induction of cross-neutralizing antibodies by a permuted hepatitis C virus glycoprotein nanoparticle vaccine candidate
Kwinten Sliepen et al.
NATURE COMMUNICATIONS (2022)
Generation of a live attenuated influenza A vaccine by proteolysis targeting
Longlong Si et al.
NATURE BIOTECHNOLOGY (2022)
Cell-penetrating peptides enhance peptide vaccine accumulation and persistence in lymph nodes to drive immunogenicity
Coralie M. Backlund et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2022)
The use of viral vectors in vaccine development
Tatianna Travieso et al.
NPJ VACCINES (2022)
A multinational Delphi consensus to end the COVID-19 public health threat
Jeffrey Lazarus et al.
NATURE (2022)
PROTACs: past, present and future
Ke Li et al.
CHEMICAL SOCIETY REVIEWS (2022)
Challenges in the use of sortase and other peptide ligases for site-specific protein modification
Holly E. Morgan et al.
CHEMICAL SOCIETY REVIEWS (2022)
Construction and characterization of UAA-controlled recombinant Zika virus by genetic code expansion
Rong-Rong Zhang et al.
SCIENCE CHINA-LIFE SCIENCES (2021)
CRISPR-Cas9: A Preclinical and Clinical Perspective for the Treatment of Human Diseases
Garima Sharma et al.
MOLECULAR THERAPY (2021)
Proteolysis targeting chimera (PROTAC) in drug discovery paradigm: Recent progress and future challenges
Shenxin Zeng et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
Merryn Voysey et al.
LANCET (2021)
Engineering precision nanoparticles for drug delivery
Michael J. Mitchell et al.
NATURE REVIEWS DRUG DISCOVERY (2021)
Next-Generation Vaccines: Nanoparticle-Mediated DNA and mRNA Delivery
William Ho et al.
ADVANCED HEALTHCARE MATERIALS (2021)
Modeling Immunity with Rosetta: Methods for Antibody and Antigen Design
Clara T. Schoeder et al.
BIOCHEMISTRY (2021)
Engineering for an HPV 9-valent vaccine candidate using genomic constitutive over-expression and low lipopolysaccharide levels in Escherichia coli cells
Kaihang Wang et al.
MICROBIAL CELL FACTORIES (2021)
AlphaFold heralds a data-driven revolution in biology and medicine
Janet M. Thornton et al.
NATURE MEDICINE (2021)
Sputnik V COVID-19 vaccine candidate appears safe and effective Comment
Ian Jones et al.
LANCET (2021)
Allergic Reactions and Anaphylaxis to LNP-Based COVID-19 Vaccines
S. Moein Moghimi
MOLECULAR THERAPY (2021)
COVID-19 Vaccine Hesitancy Worldwide: A Concise Systematic Review of Vaccine Acceptance Rates
Malik Sallam
VACCINES (2021)
SARS-CoV-2 ferritin nanoparticle vaccines elicit broad SARS coronavirus immunogenicity
M. Gordon Joyce et al.
CELL REPORTS (2021)
Safety and immunogenicity of a recombinant tandem-repeat dimeric RBD-based protein subunit vaccine (ZF2001) against COVID-19 in adults: two randomised, double-blind, placebo-controlled, phase 1 and 2 trials
Shilong Yang et al.
LANCET INFECTIOUS DISEASES (2021)
Neutralizing antibody vaccine for pandemic and pre-emergent coronaviruses
Kevin O. Saunders et al.
NATURE (2021)
Adjuvanting a subunit COVID-19 vaccine to induce protective immunity
Prabhu S. Arunachalam et al.
NATURE (2021)
Quadrivalent influenza nanoparticle vaccines induce broad protection
Seyhan Boyoglu-Barnum et al.
NATURE (2021)
Emerging concepts in the science of vaccine adjuvants
Bali Pulendran et al.
NATURE REVIEWS DRUG DISCOVERY (2021)
Latest Advances of Virology Research Using CRISPR/Cas9-Based Gene-Editing Technology and Its Application to Vaccine Development
Man Teng et al.
VIRUSES-BASEL (2021)
Recurring Revolutions in Virology
Lynn W. Enquist et al.
ANNUAL REVIEW OF VIROLOGY, VOL 8 (2021)
Protein-based antigen presentation platforms for nanoparticle vaccines
Brian Nguyen et al.
NPJ VACCINES (2021)
Lipid Nanoparticles-From Liposomes to mRNA Vaccine Delivery, a Landscape of Research Diversity and Advancement
Rumiana Tenchov et al.
ACS NANO (2021)
Genetic Code Expansion: A Brief History and Perspective
Mia A. Shandell et al.
BIOCHEMISTRY (2021)
CRISPR: History and perspectives to the future
Z. Kozovska et al.
BIOMEDICINE & PHARMACOTHERAPY (2021)
Ebola virus disease: current vaccine solutions
Oyewale Tomori et al.
CURRENT OPINION IN IMMUNOLOGY (2021)
Mammalian retrovirus-like protein PEG10 packages its own mRNA and can be pseudotyped for mRNA delivery
Michael Segel et al.
SCIENCE (2021)
Synonymous Codon Pair Recoding of the HIV-1 env Gene Affects Virus Replication Capacity
Ana Jordan-Paiz et al.
CELLS (2021)
Efficient intracellular delivery of proteins by a multifunctional chimaeric peptide in vitro and in vivo
Siyuan Yu et al.
NATURE COMMUNICATIONS (2021)
Virology, epidemiology, immunology and vaccine development of SARS-CoV-2, update after nine months of pandemic
Marc Baay et al.
BIOLOGICALS (2021)
Mosaic nanoparticles elicit cross-reactive immune responses to zoonotic coronaviruses in mice
Alexander A. Cohen et al.
SCIENCE (2021)
Adenovirus Vectors: Excellent Tools for Vaccine Development
Jun Chang
IMMUNE NETWORK (2021)
RTS,S/AS01 vaccine (Mosquirix?): an overview
Matthew B. Laurens
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2020)
Optimization of the Codon Pair Usage of Human Respiratory Syncytial Virus Paradoxically Resulted in Reduced Viral Replication In Vivo and Reduced Immunogenicity
Cyril Le Nouen et al.
JOURNAL OF VIROLOGY (2020)
Peptide-Based Vaccines: Current Progress and Future Challenges
Ryan J. Malonis et al.
CHEMICAL REVIEWS (2020)
Integrating gene delivery and gene-editing technologies by adenoviral vector transfer of optimized CRISPR-Cas9 components
Ignazio Maggio et al.
GENE THERAPY (2020)
Semisynthetic, self-adjuvanting vaccine development: Efficient, site-specific sortase A-mediated conjugation of Toll-like receptor 2 ligand FSL-1 to recombinant protein antigens under native conditions and application to a model group A streptococcal vaccine
Zhenghui Xu et al.
JOURNAL OF CONTROLLED RELEASE (2020)
PROTAC Technology: Opportunities and Challenges
Hongying Gao et al.
ACS MEDICINAL CHEMISTRY LETTERS (2020)
Mechanism of Virus Attenuation by Codon Pair Deoptimization
Nicole Groenke et al.
CELL REPORTS (2020)
A Multi-Targeting, Nucleoside-Modified mRNA Influenza Virus Vaccine Provides Broad Protection in Mice
Alec W. Freyn et al.
MOLECULAR THERAPY (2020)
Development of a new oral poliovirus vaccine for the eradication end game using codon deoptimization
Jennifer L. Konopka-Anstadt et al.
NPJ VACCINES (2020)
Genetic-Code-Expansion Strategies for Vaccine Development
Jelle A. Fok et al.
CHEMBIOCHEM (2020)
Improving efficacy of glycoconjugate vaccines: from chemical conjugates to next generation constructs
Francesco Berti et al.
CURRENT OPINION IN IMMUNOLOGY (2020)
Improving protein glycan coupling technology (PGCT) for glycoconjugate vaccine production
Jennifer Mhairi Dow et al.
EXPERT REVIEW OF VACCINES (2020)
The pore size of mesoporous silica nanoparticles regulates their antigen delivery efficiency
Xiaoyu Hong et al.
SCIENCE ADVANCES (2020)
An mRNA Vaccine against SARS-CoV-2-Preliminary Report
L. A. Jackson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
A second generation leishmanization vaccine with a markerless attenuated Leishmania major strain using CRISPR gene editing
Wen-Wei Zhang et al.
NATURE COMMUNICATIONS (2020)
Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates
Edward E. Walsh et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
De novo design of picomolar SARS-CoV-2 miniprotein inhibitors
Longxing Cao et al.
SCIENCE (2020)
SARS-CoV-2 mRNA Vaccines Foster Potent Antigen-Specific Germinal Center Responses Associated with Neutralizing Antibody Generation
Katlyn Lederer et al.
IMMUNITY (2020)
Nanoparticle Vaccines Based on the Receptor Binding Domain (RBD) and Heptad Repeat (HR) of SARS-CoV-2 Elicit Robust Protective Immune Responses
Xiancai Ma et al.
IMMUNITY (2020)
CRISPR/Cas9 Genome Editing Technology: A Valuable Tool for Understanding Plant Cell Wall Biosynthesis and Function
Yuan Zhang et al.
FRONTIERS IN PLANT SCIENCE (2020)
Targeted intracellular degradation of SARS-CoV-2 via computationally optimized peptide fusions
Pranam Chatterjee et al.
COMMUNICATIONS BIOLOGY (2020)
Rapid poxvirus engineering using CRISPR/Cas9 as a selection tool
Anjali Gowripalan et al.
COMMUNICATIONS BIOLOGY (2020)
Adjuvants for Coronavirus Vaccines
Zhihui Liang et al.
FRONTIERS IN IMMUNOLOGY (2020)
COVID-19 Crisis in Jordan: Response, Scenarios, Strategies, and Recommendations
Raeda Alqutob et al.
JMIR PUBLIC HEALTH AND SURVEILLANCE (2020)
Diverse variola virus (smallpox) strains were widespread in northern Europe in the Viking Age
Barbara Muehlemann et al.
SCIENCE (2020)
The 2019-2020 Novel Coronavirus (Severe Acute Respiratory Syndrome Coronavirus 2) Pandemic: A Joint American College of Academic International Medicine-World Academic Council of Emergency Medicine Multidisciplinary COVID-19 Working Group Consensus Paper
Stanislaw P. Stawicki et al.
JOURNAL OF GLOBAL INFECTIOUS DISEASES (2020)
Induction of Potent Neutralizing Antibody Responses by a Designed Protein Nanoparticle Vaccine for Respiratory Syncytial Virus
Jessica Marcandalli et al.
CELL (2019)
CRISPR/Cas9 technology as a potent molecular tool for gene therapy
Ansar Karimian et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
mRNA as a Transformative Technology for Vaccine Development to Control Infectious Diseases
Giulietta Maruggi et al.
MOLECULAR THERAPY (2019)
Cell-Penetrating Peptides: Efficient Vectors for Vaccine Delivery
Jieru Yang et al.
CURRENT DRUG DELIVERY (2019)
Postlicensure Safety Surveillance of Recombinant Zoster Vaccine (Shingrix) — United States, October 2017–June 2018
Elisabeth M. Hesse et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2019)
Vaccine adjuvants: Understanding the structure and mechanism of adjuvanticity
Shuting Shi et al.
VACCINE (2019)
Recent advances in the production of recombinant glycoconjugate vaccines
Emily Kay et al.
NPJ VACCINES (2019)
Targeted protein degradation: elements of PROTAC design
Stacey-Lynn Paiva et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2019)
Immunogenicity and safety of the adjuvanted recombinant zoster vaccine in adults with haematological malignancies: a phase 3, randomised, clinical trial and post-hoc efficacy analysis
Alemnew F. Dagnew et al.
LANCET INFECTIOUS DISEASES (2019)
Utilization of herpesviridae as recombinant viral vectors in vaccine development against animal pathogens
Mohamed Kamel et al.
VIRUS RESEARCH (2019)
Zika Virus Vaccine Development: Progress in the Face of New Challenges
Michael S. Diamond et al.
ANNUAL REVIEW OF MEDICINE, VOL 70 (2019)
Infectious Disease Threats in the Twenty-First Century: Strengthening the Global Response
David E. Bloom et al.
FRONTIERS IN IMMUNOLOGY (2019)
Current Advances in Chitosan Nanoparticles Based Drug Delivery and Targeting
Unnati Garg et al.
ADVANCED PHARMACEUTICAL BULLETIN (2019)
Shingrix: The New Adjuvanted Recombinant Herpes Zoster Vaccine
Stephanie F. James et al.
ANNALS OF PHARMACOTHERAPY (2018)
Non-viral delivery systems for CRISPR/Cas9-based genome editing: Challenges and opportunities
Ling Li et al.
BIOMATERIALS (2018)
CRISPR/Cas9 genome editing technology significantly accelerated herpes simplex virus research
Dong Wang et al.
CANCER GENE THERAPY (2018)
Computational protein design - the next generation tool to expand synthetic biology applications
Pablo Gainza-Cirauqui et al.
CURRENT OPINION IN BIOTECHNOLOGY (2018)
Eudragit® L100-coated mannosylated chitosan nanoparticles for oral protein vaccine delivery
Bohui Xu et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2018)
Zika Virus Attenuation by Codon Pair Deoptimization Induces Sterilizing Immunity in Mouse Models
Penghui Li et al.
JOURNAL OF VIROLOGY (2018)
Epitope-based vaccine design yields fusion peptide-directed antibodies that neutralize diverse strains of HIV-1
Kai Xu et al.
NATURE MEDICINE (2018)
Detecting and Avoiding Problems When Using the Cre-Iox System
Allisa J. Song et al.
TRENDS IN GENETICS (2018)
A simple and rapid approach to develop recombinant avian herpesvirus vectored vaccines using CRISPR/Cas9 system
Na Tang et al.
VACCINE (2018)
Potential Application of the CRISPR/Cas9 System against Herpesvirus Infections
Yuan-Chuan Chen et al.
VIRUSES-BASEL (2018)
The CRISPR tool kit for genome editing and beyond
Mazhar Adli
NATURE COMMUNICATIONS (2018)
CRISPR-Cas9, a tool to efficiently increase the development of recombinant African swine fever viruses
Manuel V. Borca et al.
SCIENTIFIC REPORTS (2018)
Post-licensure safety surveillance of zoster vaccine live (Zostavax®) in the United States, Vaccine Adverse Event Reporting System (VAERS), 2006-2015
Elaine R. Miller et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2018)
The TLR-4 agonist adjuvant, GLA-SE, improves magnitude and quality of immune responses elicited by the ID93 tuberculosis vaccine: first-in-human trial
Rhea N. Coler et al.
NPJ VACCINES (2018)
Cell penetrating peptides: A concise review with emphasis on biomedical applications
Hossein Derakhshankhah et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Rational design of a triple-type human papillomavirus vaccine by compromising viral-type specificity
Zhihai Li et al.
NATURE COMMUNICATIONS (2018)
Structure of bacterial oligosaccharyltransferase PglB bound to a reactive LLO and an inhibitory peptide
Maja Napiorkowska et al.
SCIENTIFIC REPORTS (2018)
A recombinant conjugated pneumococcal vaccine that protects against murine infections with a similar efficacy to Prevnar-13
Mark Reglinski et al.
NPJ VACCINES (2018)
Efficient control of chronic LCMV infection by a CD4 T cell epitope-based heterologous prime-boost vaccination in a murine model
Ran He et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2018)
Meningococcal Vaccines: Current Status and Emerging Strategies
Pumtiwitt C. McCarthy et al.
VACCINES (2018)
Multivalent and Multipathogen Viral Vector Vaccines
Katharina B. Lauer et al.
CLINICAL AND VACCINE IMMUNOLOGY (2017)
Adjuvant system AS01: helping to overcome the challenges of modern vaccines
Arnaud M. Didierlaurent et al.
EXPERT REVIEW OF VACCINES (2017)
Safety, immunogenicity, and preliminary clinical efficacy of a vaccine against extraintestinal pathogenic Escherichia coli in women with a history of recurrent urinary tract infection: a randomised, single-blind, placebo-controlled phase 1b trial
Angela Huttner et al.
LANCET INFECTIOUS DISEASES (2017)
Evaluating the immunogenicity and safety of a BiondVax-developed universal influenza vaccine (Multimeric-001) either as a standalone vaccine or as a primer to H5N1 influenza vaccine Phase IIb study protocol
Eva van Doorn et al.
MEDICINE (2017)
Structural Basis for the Altered PAM Recognition by Engineered CRISPR-Cpf1
Hiroshi Nishimasu et al.
MOLECULAR CELL (2017)
Expanding and reprogramming the genetic code
Jason W. Chin
NATURE (2017)
Structural basis of PROTAC cooperative recognition for selective protein degradation
Morgan S. Gadd et al.
NATURE CHEMICAL BIOLOGY (2017)
A molecular engineering toolbox for the structural biologist
Galia T. Debelouchina et al.
QUARTERLY REVIEWS OF BIOPHYSICS (2017)
The complexity and cost of vaccine manufacturing - An overview
Stanley Plotkin et al.
VACCINE (2017)
Mouse IP-10 Gene Delivered by Folate-modified Chitosan Nanoparticles and Dendritic/tumor Cells Fusion Vaccine Effectively Inhibit the Growth of Hepatocellular Carcinoma in Mice
Zixi Hu et al.
THERANOSTICS (2017)
Development of improved vaccine cell lines against rotavirus
Weilin Wu et al.
SCIENTIFIC DATA (2017)
Escherichia coli-derived virus-like particles in vaccine development
Xiaofen Huang et al.
NPJ VACCINES (2017)
Shingles (Herpes Zoster) Vaccine (Zostavax®): A Review in the Prevention of Herpes Zoster and Postherpetic Neuralgia
Gillian M. Keating
BIODRUGS (2016)
Safety and Immunogenicity of a Candidate Bioconjugate Vaccine against Shigella flexneri 2a Administered to Healthy Adults: a Single-Blind, Randomized Phase I Study
Mark S. Riddle et al.
CLINICAL AND VACCINE IMMUNOLOGY (2016)
Generation of Immunity against Pathogens via Single-Domain Antibody-Antigen Constructs
Joao N. Duarte et al.
JOURNAL OF IMMUNOLOGY (2016)
In vivo genome editing via CRISPR/Cas9 mediated homology-independent targeted integration
Keiichiro Suzuki et al.
NATURE (2016)
Genetic code expansion for multiprotein complex engineering
Christine Koehler et al.
NATURE METHODS (2016)
Dendrimer-RNA nanoparticles generate protective immunity against lethal Ebola, H1N1 influenza, and Toxoplasma gondii challenges with a single dose
Jasdave S. Chahal et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Generation of influenza A viruses as live but replication-incompetent virus vaccines
Longlong Si et al.
SCIENCE (2016)
Accurate design of megadalton-scale two-component icosahedral protein complexes
Jacob B. Bale et al.
SCIENCE (2016)
Evaluation of the attenuation, immunogenicity, and efficacy of a live virus vaccine generated by codon-pair bias de-optimization of the 2009 pandemic H1N1 influenza virus, in ferrets
Andrew J. Broadbent et al.
VACCINE (2016)
Isozygous and selectable marker-free MSTN knockout cloned pigs generated by the combined use of CRISPR/Cas9 and Cre/LoxP
Yanzhen Bi et al.
SCIENTIFIC REPORTS (2016)
A Modular Vaccine Development Platform Based on Sortase-Mediated Site-Specific Tagging of Antigens onto Virus-Like Particles
Shubing Tang et al.
SCIENTIFIC REPORTS (2016)
Liposome-Based Adjuvants for Subunit Vaccines: Formulation Strategies for Subunit Antigens and Immunostimulators
Signe Tandrup Schmidt et al.
PHARMACEUTICS (2016)
Mucoadhesive glycol chitosan nanoparticles for intranasal delivery of hepatitis B vaccine: enhancement of mucosal and systemic immune response
Dilip Pawar et al.
DRUG DELIVERY (2016)
A CRISPR/Cas9 and Cre/Lox system-based express vaccine development strategy against re-emerging Pseudorabies virus
Xun Liang et al.
SCIENTIFIC REPORTS (2016)
Recent Advances in Subunit Vaccine Carriers
Abhishek Vartak et al.
VACCINES (2016)
Coupling the CRISPR/Cas9 System with Lambda Red Recombineering Enables Simplified Chromosomal Gene Replacement in Escherichia coli
Michael E. Pyne et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2015)
A simple and rapid approach to manipulate pseudorabies virus genome by CRISPR/Cas9 system
Aotian Xu et al.
BIOTECHNOLOGY LETTERS (2015)
Secrets of a covalent interaction for biomaterials and biotechnology: SpyTag and SpyCatcher
Samuel C. Reddington et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2015)
Layer-by-Layer Assembly of Inactivated Poliovirus and N-Trimethyl Chitosan on pH-Sensitive Microneedles for Dermal Vaccination
Koen van der Maaden et al.
LANGMUIR (2015)
Codon Bias as a Means to Fine-Tune Gene Expression
Tessa E. F. Quax et al.
MOLECULAR CELL (2015)
Safety and immunogenicity of a candidate bioconjugate vaccine against Shigella dysenteriae type 1 administered to healthy adults: A single blind, partially randomized Phase I study
Christoph F. R. Hatz et al.
VACCINE (2015)
A bioinformatics tool for epitope-based vaccine design that accounts for human ethnic diversity: Application to emerging infectious diseases
Patricio Oyarzun et al.
VACCINE (2015)
Live attenuated vaccines: Historical successes and current challenges
Philip D. Minor
VIROLOGY (2015)
Varicella zoster virus infection
Anne A. Gershon et al.
NATURE REVIEWS DISEASE PRIMERS (2015)
Construction of a Live-Attenuated HIV-1 Vaccine through Genetic Code Expansion
Nanxi Wang et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2014)
SpyTag/SpyCatcher Cyclization Confers Resilience to Boiling on a Mesophilic Enzyme
Christopher Schoene et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2014)
Targeted oral delivery of BmpB vaccine using porous PLGA microparticles coated with M cell homing peptide-coupled chitosan
Tao Jiang et al.
BIOMATERIALS (2014)
Attenuation of human respiratory syncytial virus by genome-scale codon-pair deoptimization
Cyril Le Nouen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Metabolic Pitfalls of CNS Cre-Based Technology
Erika Harno et al.
CELL METABOLISM (2013)
Modern Subunit Vaccines: Development, Components, and Research Opportunities
Peter Michael Moyle et al.
CHEMMEDCHEM (2013)
Phase II and III Clinical Studies of Diphtheria-Tetanus-Acellular Pertussis Vaccine Containing Inactivated Polio Vaccine Derived from Sabin Strains (DTaP-sIPV)
Kenji Okada et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
Clinical trials of human papillomavirus vaccines and beyond
Matti Lehtinen et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2013)
Edible lipid nanoparticles: Digestion, absorption, and potential toxicity
David Julian McClements
PROGRESS IN LIPID RESEARCH (2013)
A Licensed Combined Haemophilus influenzae Type b-Serogroups C and Y Meningococcal Conjugate Vaccine
Kirsten P. Perrett et al.
INFECTIOUS DISEASES AND THERAPY (2013)
Evaluating metabolic stress and plasmid stability in plasmid DNA production by Escherichia coli
Filomena Silva et al.
BIOTECHNOLOGY ADVANCES (2012)
Lipid nanoparticles: state of the art, new preparation methods and challenges in drug delivery
Luigi Battaglia et al.
EXPERT OPINION ON DRUG DELIVERY (2012)
Risks associated with the use of live-attenuated vaccine poliovirus strains and the strategies for control and eradication of paralytic poliomyelitis
Vaia Pliaka et al.
EXPERT REVIEW OF VACCINES (2012)
Designer proteins: applications of genetic code expansion in cell biology
Lloyd Davis et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2012)
Peptide tag forming a rapid covalent bond to a protein, through engineering a bacterial adhesin
Bijan Zakeri et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Systematic review of regional and temporal trends in global rotavirus strain diversity in the pre rotavirus vaccine era: Insights for understanding the impact of rotavirus vaccination programs
Krisztian Banyai et al.
VACCINE (2012)
Aluminum Vaccine Adjuvants: Are they Safe?
L. Tomljenovic et al.
CURRENT MEDICINAL CHEMISTRY (2011)
Sortase enzymes in Gram-positive bacteria
Thomas Spirig et al.
MOLECULAR MICROBIOLOGY (2011)
Lambda Red Recombineering in Escherichia coli Occurs Through a Fully Single-Stranded Intermediate
J. A. Mosberg et al.
GENETICS (2010)
Live attenuated influenza virus vaccines by computer-aided rational design
Steffen Mueller et al.
NATURE BIOTECHNOLOGY (2010)
Rationalizing the development of live attenuated virus vaccines
Adam S. Lauring et al.
NATURE BIOTECHNOLOGY (2010)
Novel cellular and molecular mechanisms of induction of immune responses by aluminum adjuvants
Vishukumar Aimanianda et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2009)
Vaccine adjuvant systems: Enhancing the efficacy of sub-unit protein antigens
Yvonne Perrie et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2008)
Virus attenuation by genome-scale changes in codon pair bias
J. Robert Coleman et al.
SCIENCE (2008)
Replicating and non-replicating viral vectors for vaccine development
Marjorie Robert-Guroff
CURRENT OPINION IN BIOTECHNOLOGY (2007)
Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysis
Carlos G. Grijalva et al.
LANCET (2007)
Innovation: A chemical toolkit for proteins - an expanded genetic code
Jianming Xie et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2006)
The spatial dynamics of poliomyelitis in the United States: From epidemic emergence to vaccine-induced retreat, 1910-1971
B Trevelyan et al.
ANNALS OF THE ASSOCIATION OF AMERICAN GEOGRAPHERS (2005)
Expanding the genetic code
L Wang et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2005)
The biology of Gram-positive sortase enzymes
GK Paterson et al.
TRENDS IN MICROBIOLOGY (2004)
Progress and problems with the use of viral vectors for gene therapy
CE Thomas et al.
NATURE REVIEWS GENETICS (2003)